HURLY STEPHEN A 4
4 · Eleven Biotherapeutics, Inc. · Filed Jan 22, 2018
Insider Transaction Report
Form 4
HURLY STEPHEN A
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-01-18+80,430→ 80,430 totalExercise: $1.59From: 2018-01-18Exp: 2027-10-03→ Common Stock (80,430 underlying)
Footnotes (1)
- [F1]On October 4, 2017, the reporting person was granted an option to purchase 420,000 shares of common stock. This option vests in installments based on the achievement of certain strategic and clinical milestones. On January 18th, 2018, the Compensation Committee of the Board of Directors of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 80,430 shares.